MétaCan
Menu
Back to cohort

Direct-Acting Antivirals and Risk of Hepatitis C Extrahepatic Manifestations

2025· article· en· W4411208869 on OpenAlexafffundabout
Dahn Jeong, Stanley Wong, Mohammad Ehsanul Karim, Amee R. Manges, Jean Damascène Makuza, Héctor Alexander Velásquez García, Prince Adu, Mawuena Binka, Amanda Yu, Sofia Bartlett, Mel Krajden, Naveed Z. Janjua

Bibliographic record

VenueJAMA Network Open · 2025
Typearticle
Languageen
FieldMedicine
TopicHepatitis C virus research
Canadian institutionsSt. Paul's HospitalBC Centre for Disease ControlUniversity of British Columbia
FundersCanadian Institutes of Health ResearchPublic Health AgencyPublic Health Agency of CanadaGilead SciencesBritish Columbia Centre for Disease ControlProvincial Health Services AuthorityAstraZeneca
KeywordsMedicineVirologyHepatitis

Abstract

fetched live from OpenAlex

Importance: Hepatitis C virus (HCV) infection is associated with various extrahepatic manifestations (EHMs) that can significantly impact patients' quality of life and overall health outcomes. Objective: To assess the association between successful direct-acting antiviral (DAA) treatment and the risk of EHMs in individuals with chronic HCV infection. Design, Setting, and Participants: This population-based retrospective cohort study used data from 1990 to 2021, with a median follow-up of 2.5 years for outcome assessment. People treated with DAAs were matched to those who were never treated by year of HCV diagnosis and inverse probability of treatment weights (IPTW) were estimated to adjust for differences in baseline characteristics between treated and untreated people. The study took place in British Columbia, Canada, using the BC Hepatitis Testers Cohort, which includes more than 1 300 000 people tested for HCV between 1990 to 2015. Data were analyzed from February 2024 to March 2025. Exposure: Successful HCV treatment with DAAs, defined as achieving sustained virologic response (SVR). Main Outcomes and Measures: Incidence of 5 groups of EHMs: chronic kidney disease and end-stage kidney disease (CKD and ESKD), type 2 diabetes (T2D), stroke, major adverse cardiac events (MACE), and neurocognitive disorders (NCD). Results: Of 22 576 individuals included in this study (mean [SD] age at HCV diagnosis, 42.0 [12.0] years; 14 950 male [66.2%]), 11 953 received DAA treatment and achieved SVR, 386 received treatment but did not achieve SVR, and 10 237 never received treatment. The incidence rates (per 1000 person-years) in untreated vs treated with SVR groups were: 21.0 (95% CI, 19.0-23.1) vs 14.7 (95% CI, 13.4-16.1) for CKD and ESKD, 8.9 (95% CI, 7.7-10.2) vs 6.3 (95% CI, 5.5-7.2) for stroke, 26.7 (95% CI, 24.5- 29.1) vs 19.3 (95% CI, 17.8-20.9) for MACE, 19.2 (95% CI, 17.3-21.2) vs 10.3 (95% CI, 9.2-11.5) for NCD, and 6.4 (95% CI, 5.4-7.7) vs 9.2 (95% CI, 8.1-10.4) for T2D. In multivariable IPTW-weighted regression models, successful DAA treatment was associated with lower risk of CKD and ESKD (adjusted cause-specific hazard ratio [acsHR], 0.54; 95% CI, 0.47-0.63), stroke (acsHR, 0.66; 95% CI, 0.54-0.81), MACE (acsHR, 0.58; 95% CI, 0.52-0.66), and NCD (acsHR, 0.52; 95% CI, 0.45-0.61) compared with no treatment. However, no significant association was found for T2D (acsHR, 1.04; 95% CI, 0.84-1.29). Conclusions and Relevance: In this cohort study of 22 576 individuals with chronic HCV infection, successful HCV treatment with DAAs was associated with lower risk of several EHMs. These findings highlight the importance of early HCV screening and treatment to prevent EHMs and improve overall health outcomes.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.001
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.335
Threshold uncertainty score0.850

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.031
GPT teacher head0.354
Teacher spread0.323 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations7
Published2025
Admission routes3
Has abstractyes

Explore more

Same venueJAMA Network OpenSame topicHepatitis C virus researchFrench-language works237,207